At this time there is no treatment for<unk> . There is currently research being done to find treatments for<unk> . A study done in 2009 used orally administered N-acetylcysteine on<unk>  deficient mice and it prevented the symptoms associated with the disease. N-acetylcysteine is a precursor for reduced glutathione, which is decreased in<unk>  deficient patients.
Transaldolase deficiency
Enolase deficiency
Aldolase A deficiency
Glutaminase deficiency
Pyruvate kinase deficiency
Ornithine aminotransferase deficiency
Malonyl-CoA decarboxylase deficiency
Hexokinase deficiency